Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 14/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.65 |
| ▸ | MEN1 | O00255 | 3/20 | 0.65 |
| ▸ | NPC1 | O15118 | 3/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24185041 | 1.00 | GCGR (0.75) | GCGRKMT2AMEN1NPC1MAPT | |
| SCHEMBL2656321 | 0.86 | GCGR (1.00) | GCGRKMT2AMEN1NPC1 | |
| SCHEMBL2656318 | 0.86 | GCGR (1.00) | GCGRKMT2AMEN1NPC1 | |
| SCHEMBL2664301 | 0.86 | GCGR (1.00) | GCGRKMT2AMEN1 | |
| SCHEMBL32675194 | 0.86 | GCGR (0.84) | GCGRKMT2AMEN1NPC1RAB9A | |
| SCHEMBL24185310 | 0.86 | GCGR (0.84) | GCGRKMT2AMEN1NPC1RAB9A | |
| SCHEMBL32675181 | 0.84 | LMNA (0.69) | GCGRKMT2AMEN1NPC1MAPT | |
| SCHEMBL24184930 | 0.84 | LMNA (0.69) | GCGRKMT2AMEN1NPC1MAPT | |
| SCHEMBL24184915 | 0.84 | KMT2A (0.78) | GCGRKMT2AMEN1NPC1MAPT | |
| SCHEMBL32675180 | 0.84 | KMT2A (0.78) | GCGRKMT2AMEN1NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552782-B2 | Analogs of nitrofuran antibiotics to combat resistance | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2026-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552782-B2 | Analogs of nitrofuran antibiotics to combat resistance | CDC37, NRDC, SEC63 | GCGR 4048/4885KMT2A 4743/4885MEN1 4087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.